SI
SI
discoversearch

Biotech / Medical : 2017 Biotech Charity Contest

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: BulbaMan12/30/2017 1:56:17 AM
1 Recommendation

Recommended By
ghmm

   of 344
 
12/29/17 Final Contest update
(more detailed 2017 data to come, probably tomorrow)

2017 was a terrific year for biotechs, with smaller-cap companies doing especially well. And it was a banner year for Contest portfolios, with the Contest median outperforming both the NBI and SPSIBI. Of course, the year would have looked better if trading ended on December 28, but only a dotard would complain about the final 2017 numbers given the awful 2016 biotech performance. ;-)
At the Friday, 12/29/17 close, the Contest median was up 45.60% for the year, the Nasdaq Biotech Index (NBI) was up 21.06% for the year, while the smaller-cap S&P Biotechnology Select Industry Index (SPSIBI) was up 43.57% for the year. The broader market also had a good year, with the Nasdaq Composite Index (NCI) up 28.24%.
As I’ve already posted, the 2017 Contest crown goes to KMASTR’s portfolio, up an incredible 136.71% for the year! Just a smidgen behind in second place, with almost as spectacular a performance, was IMAN’s portfolio, up 135.47% for the year. Third place GHMM’s portfolio, up 118.04% for the year, also deserves kudos. And, remarkably, there were Six Contest portfolios that more than doubled for the year!
At the Dec. 29 close, 45 of the 48 portfolios were in the green for the year (in 2016 only 6 of the 58 portfolios were in the green for the year). Impressively, 37 portfolios beat the NBI and 25 beat the SPSIBI.
The 195 Contest stock picks had an average gain for the year of 38.09% and a median gain for the year of 4.86%, with 108 of the 195 Contest portfolio stocks up for 2017. The substantial difference between the average and median gain is indicative of what most biotech investors have discovered: success means a few huge winners and lots more losers.
Below is a list of 2017’s Top Ten portfolios. Also below are the Top 5 & Bottom 5 Stocks for the year, ranked by % Gained and % Lost. (Prices not converted to US$ in these Tables.)
Portfolio adjustments this week: None.
(All corrections, especially adjustments for splits, greatly appreciated.)

Links to winner KMASTR’s charity picks are:
alumniandfriends.stonybrook.edu
spendenportal.de

I’m grateful for the many thank yous for my being the Contest scorekeeper, along with your generous donations to the East Bay College Fund (www.eastbaycollegefund.org/).

Meanwhile, there are only a few more days left to post your “2018 Biotech Charity Contest” portfolios.
The deadline is: MONDAY, 1/1/2018, MIDNIGHT, PST!
Please post your 2018 portfolios here:
Subject 59918
(Especially if you’re new to the Contest, please read the guidelines in the board Introduction before posting your portfolio.)

Have a safe and fun New Year’s weekend!
Best wishes to all for a healthy, prosperous and joyful 2018!
Peace & good vibes,
Bulba

			12/29/17	
Rank Name Profit/Loss
1 KMASTR 136,710
2 IMAN 135,470
3 GHMM 118,044
4 ROBO 114,213
5 HRS 108,280
6 NIGEL 101,805
7 AJM 95,913
8 SCARAM 95,370
9 BIOMAV 94,509
10 SMALLB 93,389

		YTD Top 5 Gainers		
Symbol YE2016 12/29/17 YTD %chg.
MRNS 1.01 8.16 707.92%
PIRS 1.41 7.55 437.29%
ESPR 12.52 65.84 425.88%
NKTR 12.27 59.72 386.72%
DVAX 3.95 18.70 373.42%

YTD Bottom 5 Losers
Symbol YE2016 12/29/17 YTD %chg.
EPIX 2.19 0.21 -90.32%
MBVX 3.38 0.70 -79.29%
GNMX 5.18 1.20 -76.83%
ADOC.PA 61.00 14.35 -76.48%
MACK 40.80 10.25 -74.88%
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

Copyright © 1995-2018 Knight Sac Media. All rights reserved.Stock quotes are delayed at least 15 minutes - See Terms of Use.